Howland Capital Management LLC Reduces Holdings in Kenvue Inc. (NYSE:KVUE)

Howland Capital Management LLC lowered its position in shares of Kenvue Inc. (NYSE:KVUE) by 5.4% during the first quarter, HoldingsChannel reports. The firm owned 418,052 shares of the company’s stock after selling 23,759 shares during the period. Howland Capital Management LLC’s holdings in Kenvue were worth $8,971,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Stephens Inc. AR raised its stake in shares of Kenvue by 86.1% during the fourth quarter. Stephens Inc. AR now owns 57,694 shares of the company’s stock valued at $1,242,000 after purchasing an additional 26,700 shares during the period. Stifel Financial Corp raised its stake in shares of Kenvue by 60.4% during the fourth quarter. Stifel Financial Corp now owns 745,064 shares of the company’s stock valued at $16,041,000 after purchasing an additional 280,591 shares during the period. Raleigh Capital Management Inc. raised its stake in shares of Kenvue by 93,834.8% during the fourth quarter. Raleigh Capital Management Inc. now owns 43,210 shares of the company’s stock valued at $930,000 after purchasing an additional 43,164 shares during the period. Fifth Third Bancorp raised its stake in shares of Kenvue by 35.3% during the fourth quarter. Fifth Third Bancorp now owns 277,580 shares of the company’s stock valued at $5,976,000 after purchasing an additional 72,435 shares during the period. Finally, The Manufacturers Life Insurance Company increased its stake in shares of Kenvue by 2.6% in the fourth quarter. The Manufacturers Life Insurance Company now owns 1,598,567 shares of the company’s stock worth $34,417,000 after buying an additional 40,995 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on KVUE. HSBC lifted their price target on shares of Kenvue from $20.00 to $21.00 and gave the stock a “hold” rating in a research note on Wednesday, May 8th. William Blair began coverage on shares of Kenvue in a research note on Wednesday, April 3rd. They issued a “market perform” rating for the company. Sanford C. Bernstein began coverage on shares of Kenvue in a research note on Thursday, April 11th. They issued an “underperform” rating and a $18.00 price target for the company. Finally, Citigroup dropped their price target on shares of Kenvue from $21.00 to $20.00 and set a “neutral” rating for the company in a research note on Wednesday. One analyst has rated the stock with a sell rating, seven have given a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Kenvue presently has a consensus rating of “Hold” and a consensus target price of $23.00.

Kenvue Stock Performance

Kenvue stock traded up $0.22 during mid-day trading on Thursday, reaching $17.92. The company’s stock had a trading volume of 35,763,785 shares, compared to its average volume of 19,496,018. The firm has a market cap of $34.31 billion, a price-to-earnings ratio of 22.97, a PEG ratio of 1.93 and a beta of 1.40. The business has a 50 day moving average price of $19.02 and a 200-day moving average price of $19.80. The company has a current ratio of 0.99, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a twelve month low of $17.67 and a twelve month high of $25.61.

Kenvue (NYSE:KVUE) last released its quarterly earnings data on Tuesday, May 7th. The company reported $0.28 EPS for the quarter, topping analysts’ consensus estimates of $0.25 by $0.03. Kenvue had a net margin of 9.63% and a return on equity of 21.06%. The firm had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $3.79 billion. The business’s quarterly revenue was down 24.9% on a year-over-year basis. Sell-side analysts predict that Kenvue Inc. will post 1.17 EPS for the current fiscal year.

Kenvue Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, May 22nd. Stockholders of record on Wednesday, May 8th were issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 4.46%. The ex-dividend date was Tuesday, May 7th. Kenvue’s dividend payout ratio (DPR) is 102.56%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.